Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is pleased to announce the expansion of its leadership team with the ...

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the best small cap stocks with biggest upside potential. On August 4, Dyne ...

Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy ...

Keros Therapeutics (KROS)’ treatment of Duchenne muscular dystrophy was granted FDA orphan designation, according to a post to the agency’s site.

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...

Ryuji Morizane, MD, PhD , of the Department of Medicine at Massachusetts General Hospital, is the senior/corresponding author of a new paper published ...

First-in-human trial of Capricor's StealthX vaccine initiated under HHS's Project NextGenTrial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, ...

Welcome, listeners, now to August 19th and this issue of Circulation on the Run. And I'm one of your co-hosts, Dr. Greg Hundley, Director of the Pauley Heart Center at VCU Health in Richmond, Virginia ...

A Newry boy who's been denied access to a breakthrough new medicine has been offered some hope, after health authorities ...

A draft copy of the Make America Healthy Again Commission’s latest report, obtained by Politico, focuses on vaccine-related ...